在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Tumor necrosis factor receptor superfamily member 6B(TNFRSF6B) ELISA kit

  • 中文名稱:
    人腫瘤壞死因子受體超家族成員6B(TNFRSF6B)酶聯(lián)免疫試劑盒
  • 貨號:
    CSB-EL023982HU
  • 規(guī)格:
    96T/48T
  • 價格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人腫瘤壞死因子受體超家族成員6B(TNFRSF6B)酶聯(lián)免疫試劑盒(CSB-EL023982HU)為雙抗夾心法ELISA試劑盒,定量檢測血清、血漿、組織勻漿樣本中的TNFRSF6B含量。TNFRSF6B 作為靶點,在生物醫(yī)學研究中具有重要意義。它參與細胞多種生物學過程調(diào)節(jié)。其研究機制主要圍繞與相關(guān)配體結(jié)合,激活下游信號通路,影響細胞存活、凋亡等。深入研究有助于揭示疾病發(fā)病機制,為開發(fā)新型治療方案提供方向。試劑盒檢測范圍為0.625 ng/ml- 40 ng/ml,支持科研人員在腫瘤生物學、免疫調(diào)節(jié)機制探索、疾病模型評估等基礎(chǔ)研究中開展TNFRSF6B的動態(tài)表達研究,例如分析腫瘤組織或炎癥模型中的蛋白水平變化,或結(jié)合細胞實驗探究其功能調(diào)控通路,為相關(guān)分子機制研究提供可靠工具本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見產(chǎn)品說明書。
  • 別名:
    DcR3 ELISA Kit; Decoy receptor 3 ELISA Kit; Decoy receptor for Fas ligand ELISA Kit; DJ583P15.1.1 ELISA Kit; M68 ELISA Kit; M68E ELISA Kit; OTTHUMP00000031583 ELISA Kit; TNF6B_HUMAN ELISA Kit; TNFRSF6B ELISA Kit; TR6 ELISA Kit; Tumor necrosis factor receptor superfamily member 6B ELISA Kit; Tumor necrosis factor receptor superfamily member 6b decoy ELISA Kit; UNQ186/PRO212 ELISA Kit
  • 縮寫:
    TNFRSF6B
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, tissue homogenates
  • 檢測范圍:
    0.625 ng/ml - 40 ng/ml
  • 靈敏度:
    0.156 ng/ml
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領(lǐng)域:
    Cell Biology
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:

    Intra-assay Precision (Precision within an assay): CV%<8%

    Three samples of known concentration were tested twenty times on one plate to assess.

    Inter-assay Precision (Precision between assays): CV%<10%

    Three samples of known concentration were tested in twenty assays to assess.

  • 線性度:

    To assess the linearity of the assay, samples were spiked with high concentrations of human TNFRSF6B in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

     

    Sample

    Serum(n=4)

    1:1

    Average %

    95

    Range %

    87-99

    1:2

    Average %

    89

    Range %

    82-93

    1:4

    Average %

    91

    Range %

    88-95

    1:8

    Average %

    97

    Range %

    91-102

  • 回收率:

    The recovery of human TNFRSF6B spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.

    Sample Type

    Average % Recovery

    Range

    Serum (n=5)

    93

    82-97

    EDTA plasma (n=4)

    98

    90-102

  • 標準曲線:

    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

    ng/ml

    OD1

    OD2

    Average

    Corrected

    40

    3.002

    2.987

    2.995

    2.893

    20

    2.182

    2.113

    2.148

    2.046

    10

    1.403

    1.314

    1.359

    1.257

    5

    0.658

    0.666

    0.662

    0.560

    2.5

    0.362

    0.378

    0.370

    0.268

    1.25

    0.219

    0.214

    0.217

    0.115

    0.625

    0.138

    0.131

    0.135

    0.033

    0

    0.100

    0.104

    0.102

     

  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評價

靶點詳情

  • 功能:
    Decoy receptor that can neutralize the cytotoxic ligands TNFS14/LIGHT, TNFSF15 and TNFSF6/FASL. Protects against apoptosis.
  • 基因功能參考文獻:
    1. The combination of decoy receptor 3, soluble urokinase type plasminogen activator receptor, and procalcitonin improved the sensitivity and specificity of diagnosis of sepsis, suggesting that use of the combination of three indexes enhanced the efficiency of sepsis diagnosis. PMID: 29760745
    2. Compared with the control, miR-340 was significantly lower in the serum of hepatocellular carcinoma patients (p<0.01). miR-340 was lower in HCC tissues than in adjacent; however, DcR3, TGF-beta1 and Smad2 were higher. PMID: 29311025
    3. DcR3 treatment caused HepG2 cell cytoskeleton remodeling, inhibited E-cadherin expression, and promoted cell migration. PMID: 28560426
    4. DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma risk in Northeast Chinese females PMID: 27517320
    5. Study found that both transcriptional expression and post-transcriptional DcR3 expression DcR3 expression were significantly up-regulated in colorectal cancer (CRC) tissues. DcR3 was found to be playing a critical role in CRC proliferation and migration in vitro and in tumorigenesis and metastasis in vivo. PMID: 27764793
    6. Higher plasma DcR3 level was related to better coronary collateral circulation (CCC) formation and displayed potent predictive power for CCC status in patients with coronary artery disease. PMID: 28942284
    7. High serum DcR3 levels are associated with disease severity in nonatopic asthma patients. PMID: 26911723
    8. Results show that DcR3 engages TNF ligands: FasL, LIGHT, and TL1A in a structurally similar fashion and its promiscuity is due to recognition of backbone atoms and invariant side chains. PMID: 27806260
    9. when idiopathic pulmonary fibrosis cells interact with collagen matrix, aberrantly activated Akt increases DcR3 expression via GSK-3beta-NFATc1 and protects IPF cells from the FasL-dependent apoptotic pathway. PMID: 27218286
    10. Coexpression of TNFRSF6B and PCDHGA3 was observed immunohistochemically in FL18 cells, suggesting potential cooperation in tumor cell maintenance. PMID: 27748813
    11. Loss of DcR3 impaired the growth and invasive property of HCC cell line of HepG2. PMID: 27779171
    12. Overexpression of DcR3 was significantly related to the risk of female reproductive cancers (OR=10.69, 95% CI: 6.33-18.05), TNM stage (OR=5.51, 95% CI: 2.83-10.71), differentiation (OR=4.16, 95% CI: 2.28-7.60), lymph node metastasis (OR=5.89, 95% CI: 3.16-10.9), age (OR=0.85, 95% CI: 0.51-1.44), and overall survival time (OR=1.84, 95% CI: 0.58-5.83). PMID: 27246752
    13. The serum level of DcR3 may be a useful marker for disease activity in ANCA-associated renal vasculitis. PMID: 27251675
    14. The sDcR3 levels in patients with HIV-1 subtype B were significantly higher than those in patients infected with subtype CRF01_AE. HIV-1 subtype B and slow disease progression were associated with higher levels of sDcR3. PMID: 26062966
    15. DcR3 inhibits influenza a virus-induced JNK and ERK activation in human macrophages PMID: 25940317
    16. Decoy receptor 3 (DcR3) expression in kidneys has been shown to predict progression of chronic kidney disease. PMID: 26335204
    17. Decoy receptor 3 regulates the expression of tryptophan hydroxylase 1 in rheumatoid synovial fibroblasts PMID: 26238767
    18. tumour markers DcR3 and growth/differentiation factor (GDF)15 from 100 mul human serum, were quantified. PMID: 25823874
    19. Serum DcR3 expression in primary Sjogren's syndrome (pSS) patients was significantly higher than healthy controls. DcR3 expression in salivary glands of pSS patients was significantly higher than healthy controls. PMID: 25564309
    20. study has defined the increased serum and SF samples levels of TL1A and DcR3 in patients with rheumatoid arthritis (RA); findings support the hypothesis that TL1A and DcR3 may contribute to the pathogenesis of RA PMID: 25647275
    21. decoy receptor 3 and geriatric nutrition have a role in mortality in chronic hemodialysis patients PMID: 25323840
    22. Higher DcR3 expression was related to the status of invasion, lymph node metastasis and recurrence in bladder urothelial carcinoma. PMID: 25422191
    23. HER2 overexpression is not an independent prognostic marker of colorectal cancer, but DcR3 overexpression is highly correlated with lymph node metastasis and poor overall survival PMID: 24764685
    24. The overexpression of DcR3 might play a crucial role in the tumorigenesis, differentiation, and proliferation of glioma. PMID: 24741354
    25. Overexpression of TNFRSF6B is associated with hepatocellular carcinoma. PMID: 24998573
    26. A case-control study of esophageal squamous-cell carcinoma (ESCC)found that the DcR3 SNPs were not associated with the risk of ESCC. PMID: 24786982
    27. Inhibition of B cell functions by DcR3 may partially explain the negative correlation between DcR3 level and disease activity in rheumatoid arthritis patients. PMID: 25084482
    28. High serum DcR3 expression correlated with lymph node metastases in in pancreatic head carcinoma PMID: 24597666
    29. DcR3 is a key driver of tumor cell dissemination. PMID: 24107265
    30. DcR3 may play an etiologic role in systemic lupus erythematosus through either elevated serum levels of wild-type DcR3 or normal levels of gain-of-function DcR3 proteins that increase lymphocyte proliferation. PMID: 23729807
    31. Rare missense mutations in TNFRSF6B have a role in the pathogenesis of some cases of IBD. PMID: 23965943
    32. DCR3 is overexpressed in breast cancer and in vascular endothelial cells and tumor cells in the lymph nodes, revealing a possible link with lymphangiogenesis. PMID: 24612949
    33. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo. PMID: 23846297
    34. Our results implied the therapeutic potential of silencing DcR3 expression by RNAi in colon cancer. PMID: 24101127
    35. The findings in this study strongly suggest that DcR3 plays important roles in tumor progression of human MFH by decoy as well as non-decoy functions and that DcR3 may serve as a potent therapeutic target for human MFH. PMID: 23817777
    36. Serum DcR3 level may be useful for detecting Hepatitis Be Antigen (-) Chronic hepatitis B in the active stage, which requires medical treatment. PMID: 23925044
    37. DcR3 might regulate the gene expression of various key molecules in rheumatoid arthritis fibroblast-like synoviocytes by binding to TL1A. PMID: 23912906
    38. Data suggest DcR3 expression in DSV-PTC (diffuse sclerosing variant of papillary thyroid carcinoma) tumor cells promotes polarized macrophage differentiation toward the M2 phenotype and thus has role in recruitment of tumor-associated macrophages. PMID: 23186064
    39. high expression of TNFRSF6B is a novel biomarker for predicting the progression of chronic kidney disease PMID: 23449012
    40. DcR3 expression was associated with other prognostic factors including survivin, reduced remission rates, and shorter event-free survival. PMID: 23652586
    41. novel regulatory mechanisms of DcR3 expression in psoriasis, particularly in keratinocytes and endothelial cells, provides new insight into the pathogenesis of psoriasis PMID: 23707413
    42. DcR3 and ERK1/2 play a vital role in the development of gastric cancer, and they may be new markers for indicating the efficiency of gastric cancer treatment in the future. PMID: 22672288
    43. Higher DcR3 levels strongly correlate with inflammation and independently predict cardiovascular and all-cause mortality in CKD patients on hemodialysis. PMID: 22626963
    44. High expression and amplification of the DcR3 gene is associated with pancreatic carcinoma. PMID: 22524850
    45. These results imply that DcR3 may regulate B cell activation by suppressing the activation of NF-kappaB. PMID: 22581854
    46. The increased synovial inflammatory cells infiltration in rheumatoid arthritis and ankylosing spondylitis was associated with the elevated DCR3 expression. PMID: 22325083
    47. Significantly enhanced tumor growth and spreading are observed in DcR3-transgenic mice; DcR3-transfectant cells grow faster and result in infiltration by tumor-associated macrophages. PMID: 22287720
    48. The expression of DcR3 in vascular endothelial cells during the early phases of Kaposi's sarcoma-associated herpesvirus infection ensures the successful establishment and maintenance of the viral infection. PMID: 21293109
    49. DcR3-Fc inhibits the proliferation induced by TNFalpha or IL-1beta in rheumatoid arthritis. PMID: 21537832
    50. EMS1 expression was positively related to DcR3, which might play an important role in the carcinogenesis and development of laryngeal carcinoma. PMID: 21395182

    顯示更多

    收起更多

  • 亞細胞定位:
    Secreted.
  • 組織特異性:
    Detected in fetal lung, brain and liver. Detected in adult stomach, spinal cord, lymph node, trachea, spleen, colon and lung. Highly expressed in several primary tumors from colon, stomach, rectum, esophagus and in SW480 colon carcinoma cells.
  • 數(shù)據(jù)庫鏈接:

    HGNC: 11921

    OMIM: 603361

    KEGG: hsa:8771

    STRING: 9606.ENSP00000359013

    UniGene: Hs.434878



主站蜘蛛池模板: 无码高潮爽到爆的喷水视频| www亚洲精品少妇裸乳一区二区| 5858s亚洲色大成网站www| 国产成人精品一区二区三区免费| 亲嘴扒胸摸屁股激烈网站 | 潮喷失禁大喷水无码| 国产偷人妻精品一区二区在线 | 女女同性av片在线观看免费| 色狠狠色噜噜av天堂一区| 亚洲色大成网站www永久一区| 水蜜桃精品一二三| 久久综合久久自在自线精品自| 国产精品亚洲а∨天堂| 波多野结衣一区二区免费视频| 伊人久久精品亚洲午夜| 爱情岛论坛网亚洲品质 | 精品少妇无码av无码专区| 五级黄高潮片90分钟视频| 国产做无码视频在线观看浪潮| 国内外精品激情刺激在线| 国内精品久久久久影院免费| 免费看国产成年无码av| 97国产一区二区三区四区久久| 日本一区二区三区免费播放| 成年美女黄网站色大片免费看| 久碰久摸久看视频在线观看| 天天躁日日躁狠狠躁超碰97| 日韩在线一区二区三区免费视频| 2020国产欧洲精品网站| 国产在线拍揄自揄视频网试看| 中文字幕+乱码+中文字幕一区| 人妻在线无码一区二区三区 | 久久久久成人网站| 国产乱人伦偷精品视频免下载| 久久综合九色综合97伊人| 国产欧美日韩综合在线成| 亚洲综合欧美在线一区在线播放| 久久精品国产日本波多野结衣| 中字幕视频在线永久在线观看免费| 狠狠色狠狠色综合日日不卡| 漂亮人妻熟睡中被公侵犯中文版|